SCHEMBL5204074

SCHEMBL5204074

CC1=NN(c2ccc(I)cc2)C(=O)C1/N=N/C1C(=O)N(c2ccc(C(=O)O)cc2)N=C1C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 7/20 0.52
▸ ALDH1A1 P00352 5/20 0.52
▸ SMN1; SMN2 Q16637 4/20 0.52
▸ LMNA P02545 4/20 0.52
▸ NPC1 O15118 3/20 0.52
▸ TDP1 Q9NUW8 2/20 0.52
▸ RAB9A P51151 2/20 0.52
▸ MAPK1 P28482 1/20 0.52
▸ MEN1 O00255 6/20 0.47
▸ KMT2A Q03164 6/20 0.47
▸ POLB P06746 2/20 0.47
▸ KDM4E B2RXH2 2/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ ATM Q13315 1/20 0.46
▸ HTT P42858 2/20 0.44
▸ PKM P14618 1/20 0.44
▸ CYP1A2 P05177 2/20 0.44
▸ GAA P10253 1/20 0.44
▸ TPMT P51580 1/20 0.44
▸ CYP2C9 P11712 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5204078 1.00 MAPT (0.52) MAPTALDH1A1SMN1; SMN2LMNANPC1
SCHEMBL5202290 0.88 MEN1 (0.53) MAPTALDH1A1SMN1; SMN2LMNANPC1
SCHEMBL5202292 0.88 MEN1 (0.53) MAPTALDH1A1SMN1; SMN2LMNANPC1
SCHEMBL5202286 0.88 MEN1 (0.53) MAPTALDH1A1SMN1; SMN2LMNANPC1
SCHEMBL5206340 0.88 MAPT (0.50) MAPTALDH1A1SMN1; SMN2LMNANPC1
SCHEMBL5202737 0.88 MAPT (0.50) MAPTALDH1A1SMN1; SMN2LMNANPC1
SCHEMBL5204522 0.85 MAPT (0.50) MAPTALDH1A1SMN1; SMN2LMNANPC1
SCHEMBL5204527 0.85 MAPT (0.50) MAPTALDH1A1SMN1; SMN2LMNANPC1
SCHEMBL7165140 0.84 KMT2A (0.51) MAPTALDH1A1SMN1; SMN2LMNANPC1
SCHEMBL7165995 0.83 MAPT (0.48) MAPTALDH1A1SMN1; SMN2LMNANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1223944-B1 THROMBOPOIETIN MIMETICS SMITHKLINE BEECHAM CORP (US) 2007-01-03 — — EP claimed
US-6552008-B1 Administering effective amount of a selected azo-pyrazole derivative for therapy of thrombocytopenia SMITHKLINE BEECHAM CORPORATION 2003-04-22 — — US claimed
JP-2003509462-A — — 2003-03-11 — — JP claimed
EP-1223944-A4 THROMBOPOIETIN MIMETICS SMITHKLINE BEECHAM CORP (US) 2002-10-30 — — EP claimed
EP-1223944-A1 THROMBOPOIETIN MIMETICS SmithKline Beecham Corporation (US) 2002-07-24 — — EP claimed
WO-2001021180-A1 THROMBOPOIETIN MIMETICS SMITHKLINE BEECHAM CORPORATION (US) 2001-03-29 — — WO claimed
EP-1223944-B1 THROMBOPOIETIN MIMETICS SMITHKLINE BEECHAM CORP (US) 2007-01-03 — — EP disclosed
US-6552008-B1 Administering effective amount of a selected azo-pyrazole derivative for therapy of thrombocytopenia SMITHKLINE BEECHAM CORPORATION 2003-04-22 — — US disclosed
EP-1223944-A4 THROMBOPOIETIN MIMETICS SMITHKLINE BEECHAM CORP (US) 2002-10-30 — — EP disclosed
EP-1223944-A1 THROMBOPOIETIN MIMETICS SmithKline Beecham Corporation (US) 2002-07-24 — — EP disclosed
WO-2001021180-A1 THROMBOPOIETIN MIMETICS SMITHKLINE BEECHAM CORPORATION (US) 2001-03-29 — — WO disclosed
Send feedback